However, Sanjay Kakar et al[33] reported that KRAS mutations in codons 12 and 13 were observed in half of signet-ring cell carcinomas, which was similar to the rate in conventional adenocarcinomas. This evidence concerns the gene KRAS and adenocarcinoma.